Form D — Acurx Pharmaceuticals, Inc.
0001104659-25-063623 · filed 2025-06-27
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $3,978,664
- Total sold
- $3,978,664
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Acurx Pharmaceuticals, Inc.
- CIK
- 1736243
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 259 LIBERTY AVENUE
STATEN ISLAND, NY 10305 - Phone
- 917-533-1469
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
DAVID P. LUCI · Executive OfficerSTATEN ISLAND, NY Find on LinkedIn ↗
-
ROBERT J. DELUCCIA · Executive OfficerSTATEN ISLAND, NY Find on LinkedIn ↗
-
ROBERT G. SHAWAH · Executive OfficerSTATEN ISLAND, NY Find on LinkedIn ↗
-
JACK H. DEAN · DirectorSTATEN ISLAND, NY Find on LinkedIn ↗
-
JAMES DONOHUE · DirectorSTATEN ISLAND, NY Find on LinkedIn ↗
-
THOMAS HARRISON · DirectorSTATEN ISLAND, NY Find on LinkedIn ↗
-
CARL SAILER · DirectorSTATEN ISLAND, NY Find on LinkedIn ↗
-
JOSEPH SCODARI · DirectorSTATEN ISLAND, NY Find on LinkedIn ↗
View original on SEC EDGAR.